The nurse is providing instructions to the patient diagnosed with Multiple Sclerosis (MS) about baclofen. What would the nurse emphasize in the instructions?

A. Respiratory rate 26, irregular: Pt reports no shortness of breath or chills: An irregular respiratory rate may indicate some underlying issues. Although the patient reports no shortness of breath or chills, an irregular respiratory rate could signal a cardiac issue or a lingering effect of the infection. It’s not sufficient to confirm the effectiveness of antibiotic therapy.

B. Temp-99F (37.2°C); Lungs clear bilaterally; Pulse ox 98% on 2 liters oxygen; productive cough: clear to yellow sputum: This indicates improvement in the patient’s condition:

A temperature of 99°F is a mild, controlled fever, which is common in the recovery phase but suggests a reduction from higher fever associated with infection.

Clear lungs bilaterally are a good sign, indicating that there is no longer significant consolidation or inflammation in the lungs.

Pulse oximetry of 98% on 2 liters of oxygen is a positive sign that the oxygenation is improving.

Productive cough with yellow sputum indicates that the body is still clearing the infection, but it is a typical sign of recovery as the patient produces sputum.

C. Pt reports fatigue: Resp rate 28 on 2 liters oxygen: audible expiratory wheezes: This is concerning. The patient is still experiencing fatigue and audible wheezes, which may indicate unresolved inflammation or bronchoconstriction. The respiratory rate of 28, while slightly elevated, also suggests ongoing respiratory stress. This could indicate that the infection is not fully controlled.

D. Cough: white sputum: Temp 99F (37.2°C); Pulse ox 96%: This is somewhat positive, but it lacks the detail of clear lungs or other more definitive signs of improvement. The white sputum could suggest that the infection is resolving, but there is still some degree of infection or inflammation. Pulse ox at 96% is acceptable, but the lack of clear lungs bilaterally makes it less ideal.

A. removes the client's blood and returns high-dose corticosteroids to the patient: Plasmapheresis involves the removal of plasma from the blood, but it does not involve returning high-dose corticosteroids. It removes harmful substances (such as autoantibodies) from the plasma that contribute to disease symptoms, but it does not involve corticosteroid therapy directly.

B. removes the autoantibodies responsible for Myasthenia Gravis: In Myasthenia Gravis (MG), autoantibodies attack the acetylcholine receptors at the neuromuscular junction, leading to muscle weakness. Plasmapheresis is used to remove these autoantibodies from the bloodstream, helping to temporarily improve symptoms by reducing the immune system’s attack on the body’s own tissues.

C. treats the thymus gland dysfunction responsible for Myasthenia Gravis: Plasmapheresis does not directly treat the thymus gland. In some cases, thymectomy (removal of the thymus gland) may be indicated for MG, but plasmapheresis specifically addresses the immune response, not the thymus.

D. assists in the immune suppression along with corticosteroids: While plasmapheresis can temporarily reduce the autoimmune response, it does not function as a form of immune suppression like corticosteroids. Corticosteroids are immunosuppressive medications, but plasmapheresis itself is a physical process that removes harmful autoantibodies from the blood